DK98692D0 - Monoklonalt antistof og fremgangsmaade til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og proeve for tumorcellefoelsomhed under anvendelse af det monoklonale antistof - Google Patents

Monoklonalt antistof og fremgangsmaade til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og proeve for tumorcellefoelsomhed under anvendelse af det monoklonale antistof

Info

Publication number
DK98692D0
DK98692D0 DK92986A DK98692A DK98692D0 DK 98692 D0 DK98692 D0 DK 98692D0 DK 92986 A DK92986 A DK 92986A DK 98692 A DK98692 A DK 98692A DK 98692 D0 DK98692 D0 DK 98692D0
Authority
DK
Denmark
Prior art keywords
cells
new
monoclonal antibody
tumour
producing
Prior art date
Application number
DK92986A
Other languages
English (en)
Other versions
DK98692A (da
DK170423B1 (da
Inventor
Janet H Ransom
Richard P Mccabe
Martin V Haspel
Nicholas Pomato
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK98692D0 publication Critical patent/DK98692D0/da
Publication of DK98692A publication Critical patent/DK98692A/da
Application granted granted Critical
Publication of DK170423B1 publication Critical patent/DK170423B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK098692A 1984-04-13 1992-08-04 Monoklonalt antistof, der er specifikt for leukoregulincelleoverfladereceptorer, og fremgangsmåde til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og prøve for tumorcellefølsomhed under anvendelse af det monoklonale antistof DK170423B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60030384A 1984-04-13 1984-04-13
US60030384 1984-04-13

Publications (3)

Publication Number Publication Date
DK98692D0 true DK98692D0 (da) 1992-08-04
DK98692A DK98692A (da) 1992-08-04
DK170423B1 DK170423B1 (da) 1995-08-28

Family

ID=24403068

Family Applications (2)

Application Number Title Priority Date Filing Date
DK562285A DK170781B1 (da) 1984-04-13 1985-12-04 Human leukoregulin og biologisk aktive underenheder deraf, fremgangsmåde til fremstilling og til oprensning af human leukoregulin, biologisk aktivt materiale indeholdende human leukoregulin samt celle, som producerer human leukoregulin
DK098692A DK170423B1 (da) 1984-04-13 1992-08-04 Monoklonalt antistof, der er specifikt for leukoregulincelleoverfladereceptorer, og fremgangsmåde til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og prøve for tumorcellefølsomhed under anvendelse af det monoklonale antistof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK562285A DK170781B1 (da) 1984-04-13 1985-12-04 Human leukoregulin og biologisk aktive underenheder deraf, fremgangsmåde til fremstilling og til oprensning af human leukoregulin, biologisk aktivt materiale indeholdende human leukoregulin samt celle, som producerer human leukoregulin

Country Status (9)

Country Link
EP (1) EP0179127B1 (da)
JP (2) JP2562014B2 (da)
AT (1) ATE48617T1 (da)
AU (2) AU592529B2 (da)
DE (1) DE3574710D1 (da)
DK (2) DK170781B1 (da)
FI (1) FI85867C (da)
NO (1) NO170423C (da)
WO (1) WO1985004662A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3574710D1 (de) * 1984-04-13 1990-01-18 Litton Bionetics Inc Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US6087166A (en) 1997-07-03 2000-07-11 Basf Aktiengesellschaft Transcriptional activators with graded transactivation potential
JP2009537139A (ja) 2006-05-15 2009-10-29 パラテック ファーマシューティカルズ インコーポレイテッド 置換されたテトラサイクリン化合物を用いて、遺伝子または遺伝子産物の発現を制御する方法
WO2012156535A1 (en) 2011-05-19 2012-11-22 Fundación Progreso Y Salud Highly inducible dual-promoter lentiviral tet-on system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4403035A (en) * 1981-06-19 1983-09-06 Regents Of The University Of Minnesota In vitro DNA-Protein viral assembly and gene cloning system
DE3138230A1 (de) * 1981-09-25 1983-04-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von makrophagen- aktivierungsfaktor (maf)
JPS6011889B2 (ja) * 1981-10-28 1985-03-28 電気化学工業株式会社 継代可能なリンホカイン産生ヒトt細胞融合株及びその取得方法
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
DE3574710D1 (de) * 1984-04-13 1990-01-18 Litton Bionetics Inc Leukoregulin, ein antitumor-lymphokin und dessen verwendung als heilmittel.

Also Published As

Publication number Publication date
JPS61501853A (ja) 1986-08-28
DK562285D0 (da) 1985-12-04
EP0179127A1 (en) 1986-04-30
JPH06253832A (ja) 1994-09-13
DK98692A (da) 1992-08-04
FI85867C (fi) 1992-06-10
DK170781B1 (da) 1996-01-15
NO170423C (no) 1992-10-14
DK562285A (da) 1985-12-04
AU641386B2 (en) 1993-09-23
AU4234185A (en) 1985-11-01
NO854994L (no) 1985-12-12
WO1985004662A1 (en) 1985-10-24
AU5365390A (en) 1990-09-20
AU592529B2 (en) 1990-01-18
DE3574710D1 (de) 1990-01-18
DK170423B1 (da) 1995-08-28
JP2562014B2 (ja) 1996-12-11
FI854803A (fi) 1985-12-04
NO170423B (no) 1992-07-06
FI85867B (fi) 1992-02-28
FI854803A0 (fi) 1985-12-04
EP0179127A4 (en) 1986-08-21
JP2564245B2 (ja) 1996-12-18
EP0179127B1 (en) 1989-12-13
ATE48617T1 (de) 1989-12-15

Similar Documents

Publication Publication Date Title
Chen et al. A strategy to discover circulating angiogenesis inhibitors generated by human tumors
Androphy et al. Identification of the protein encoded by the E6 transforming gene of bovine papillomavirus
Kfir et al. Monoclonal antibody specific for cyanoginosin-LA: preparation and characterization
ZA9410282B (en) Immunoconjugates
ES2154354T3 (es) Ligandos tie-2, metodos para obtenerlos y sus usos.
BG43355A3 (en) Method for preparing of physiologically active polypeptide
DK40885D0 (da) Monoklonalt antistof, fremgangsmaade og celle til fremstilling deraf,fremgangsmaade til fremstilling af cellen og farmaceutisk praeparat indeholdende det monoklonale antistof
DK98692D0 (da) Monoklonalt antistof og fremgangsmaade til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og proeve for tumorcellefoelsomhed under anvendelse af det monoklonale antistof
Kudlow et al. Inability of anti-epidermal growth factor receptor monoclonal antibody to block “autocrine” growth stimulation in transforming growth factor-secreting melanoma cells.
Troppmair et al. An altered v-raf is required in addition to v-myc in J3V1 virus for acceleration of murine plasmacytomagenesis.
Tagliaferri et al. Two classes of cAMP analogs synergistically inhibit p21 ras protein synthesis and phenotypic transformation of NIH3T3 cells transfected with Ha-MuSV DNA
CN108463730A (zh) 包含重组人促甲状腺激素的组合物以及生产重组人促甲状腺激素的方法
Miletić et al. The effect of X-irradiation on the degradation of DNA in closely-related strains of E. coli
AU2001220255A1 (en) Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector
Raška Jr et al. Double-stranded DNA binding of adenovirus type 12 tumor antigen
EP1006125B1 (en) Goat epididymal forward motility protein
Choi et al. Production and characterization of monoclonal antibodies to bovine brain GABA transaminase
EP0950062A4 (en) PROTEIN MARKER FOR OESOPHAGUS CANCER
DE58907987D1 (de) Pyruvatkinase-isoenzyme typ m2 (tumor m2-pk) - spezifische antikörper/verfahren zu deren herstellung und deren verwendung.
Matsumoto et al. Stimulation of bone collagenase synthesis by mouse fibrosarcoma in resorbing bone in vitro culture
JPH03505575A (ja) 幹細胞阻害剤
Greenberger et al. Biochemical Purification of a CSF-1 like Molecule Released during Malignant Transformation of IL-3 Dependent Hematopoietic Progenitor cell lines Cocultivated with Gamma Irradiated Clonal Marrow Stromal cell lines
LINES et al. Department Of Radiation Oncology, University Of Massachusetts Medical Center, Worcester, MA 01655 Cocultivation of IL-3 dependent hematopoietic progenitor cell line FDC-P1JL26 with 5000 cGy irradiated clonal bone marrow
Loschke Studies on the Synthesis of Phenylalanine Ammonia-lyase in Peas
Ball Leghemoglobin biosynthesis in soybean root nodules

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed